3 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 3 |
| Phase 1 | 1 | Recruiting 1 |
Follow Cerebral Infarction: new trials by email Literature Review of Cerebral Infarction trials Research Report on Cerebral Infarction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage Xenon, air/oxygen - Subarachnoid Hemorrhage, Aneurysmal, Cerebral Injury | Phase 2 | Recruiting | Turku University Hospital | 160 | 2025-04-22 | 2025-05-01 |
| A Dose-Response Controlled Trial of Bevifibatide for Acute Ischemic Stroke Bevifibatide citrate injection - Ischemic Stroke, Acute, Ischemic Stroke | Phase 2 | Recruiting | Zhujiang Hospital | 40 | 2025-02-10 | 2025-07-17 |
| Retina is a Marker for Cerebrovascular Heath Cilostazol - Cerebral Small Vessel Diseases, Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy | Phase 1 / Phase 2 | Recruiting | Mayo Clinic | 100 | 2021-02-09 | 2026-08-03 |
Brain Diseases (1) · Brain Injuries (1) · Brain Ischemia (1) · CADASIL (1) · Cardiovascular Diseases (1) · Cerebral Small Vessel Diseases (1) · Heart Failure (1) · Ischemic Stroke (1) · Subarachnoid Hemorrhage (1)
Brain Infarction (3) · Central Nervous System Diseases (3) · Cerebrovascular Disorders (3) · Infarction (3) · Ischemia (3) · Necrosis (3) · Nervous System Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Stroke (3) · Vascular Diseases (3) · Brain Diseases (2) · Brain Ischemia (2) · Cardiovascular Diseases (2) · Cerebral Arterial Diseases (1)
Cilostazol (1) · Xenon (1)
Mayo Clinic (1) · Turku University Hospital (1) · Zhujiang Hospital (1)
China (1) · Finland (1) · Sweden (1) · United States (1)
Chuanzhi Duan, MD (1) · Michelle P Lin, MD, MPH (1) · Timo T Laitio, MD, PhD (1)
PMID 26978207, PMID 29169472, PMID 37337295
2019 (1)